Overview
NHI market data
Price History
NHI price chart
Valuation & Profitability
- P/E (TTM)
- 23.73 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $3.02 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.51 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 5.3% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 36.9% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $67.94 – $91.38 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $3.5B · P/B 2.43 · P/S 8.76.
Company News
National Health Investors shares are trading lower after the company reported worse-than-expected Q2 FFO results.Benzinga · Aug 11, 2026, 3:06 PM
National Health Investors Affirms FY2026 FFO Guidance of $4.74-$4.79 vs $4.84 EstBenzinga · Aug 10, 2026, 8:17 PM
8-K filing — NATIONAL HEALTH INVESTORS INC (NHI)SEC EDGAR · Aug 10, 2026, 8:12 PM
National Health Investors Q2 FFO $1.19 Misses $1.26 Estimate, Sales $121.319M Beat $111.677M EstimateBenzinga · Aug 10, 2026, 8:07 PM
National Health Investors Adds Former Longview CEO Chris Maingot As COOBenzinga · Jul 27, 2026, 10:10 AM
Deutsche Bank Maintains Hold on National Health Investors, Lowers Price Target to $80Benzinga · Jun 25, 2026, 4:45 PM
National Health Investors To Replace Apollo Commercial Real Estate Finance In The S&P SmallCap 600 Effective Prior To The Opening Of Trading On Tuesday, June 30Benzinga · Jun 23, 2026, 9:30 PM
BMO Capital Maintains Outperform on National Health Investors, Lowers Price Target to $80Benzinga · Jun 15, 2026, 3:05 PM
Truist Securities Maintains Buy on National Health Investors, Lowers Price Target to $81Benzinga · Jun 12, 2026, 2:20 PM
National Health Investors Clears HSR Review For Sale Of 35 Senior Housing And Skilled Nursing Properties, Closing Expected July 1Benzinga · Jun 1, 2026, 8:24 PM